<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bacterial susceptibility &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/bacterial-susceptibility/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 13 Dec 2025 03:19:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Bacterial susceptibility &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>G-CSF/NAMPT Signaling Boosts Infection Risk in Cancer</title>
		<link>https://bioengineer.org/g-csf-nampt-signaling-boosts-infection-risk-in-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 03:19:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bacterial susceptibility]]></category>
		<category><![CDATA[Cancer infections]]></category>
		<category><![CDATA[G-CSF/NAMPT signaling]]></category>
		<category><![CDATA[immunometabolism]]></category>
		<category><![CDATA[Neutrophil dysfunction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/g-csf-nampt-signaling-boosts-infection-risk-in-cancer/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape our understanding of immune dysfunction in cancer patients, researchers have uncovered a pivotal signaling pathway that compromises the frontline defense of the human immune system. Published in Nature Communications, the research led by Pylaeva, Tollrian, Riedesel, and colleagues elucidates how the interplay between granulocyte-colony stimulating factor (G-CSF) and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307080</post-id>	</item>
	</channel>
</rss>
